ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Humanized Bisspecific Antibody Market Research Report 2025
Published Date: 2025-12-23
|
Report Code: QYRE-Auto-6L18424
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Humanized Bisspecific Antibody Market Research Report 2024
BUY CHAPTERS

Global Recombinant Humanized Bisspecific Antibody Market Research Report 2025

Code: QYRE-Auto-6L18424
Report
2025-12-23
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
SUNSHINE GUOJIAN PHARMACEUTICAL
Akeso, Inc.
ALPHAMAB ONCOLOGY
Junshi Biosciences
CSPC Pharmaceutical Group
Milestone (Shanghai) Biological Science & Technology
Detai Bio-Tech
Milestone (Shanghai) Biological Science & Technology

Recombinant Humanized Bisspecific Antibody Market

The global market for Recombinant Humanized Bisspecific Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Recombinant humanized bisspecific antibody used CTLA-4 single domain antibody with significantly improved safety. Fusion with PD-L1 antibody to form bispecific antibody; It can target the tumor microenvironment enriched with high expression of PD-L1 and clear Treg.
North American market for Recombinant Humanized Bisspecific Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Humanized Bisspecific Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Recombinant Humanized Bisspecific Antibody include Sunshine Guojian Pharmaceutical, Milestone (Shanghai) Biological Science & Technology, Akeso, Inc, Alphamab Oncology, Detai Bio-Tech, Junshi Biosciences, CSPC Pharmaceutical Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Humanized Bisspecific Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Humanized Bisspecific Antibody.
The Recombinant Humanized Bisspecific Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Humanized Bisspecific Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Humanized Bisspecific Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Humanized Bisspecific Antibody Market Report

Report Metric Details
Report Name Recombinant Humanized Bisspecific Antibody Market
Segment by Type
  • With Fc Area
  • No Fc Area
Segment by Application
  • Breast Cancer
  • Stomach Cancer
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sunshine Guojian Pharmaceutical, Milestone (Shanghai) Biological Science & Technology, Akeso, Inc, Alphamab Oncology, Detai Bio-Tech, Junshi Biosciences, CSPC Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Humanized Bisspecific Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Humanized Bisspecific Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Recombinant Humanized Bisspecific Antibody Market report?

Ans: The main players in the Recombinant Humanized Bisspecific Antibody Market are Sunshine Guojian Pharmaceutical, Milestone (Shanghai) Biological Science & Technology, Akeso, Inc, Alphamab Oncology, Detai Bio-Tech, Junshi Biosciences, CSPC Pharmaceutical Group

What are the Application segmentation covered in the Recombinant Humanized Bisspecific Antibody Market report?

Ans: The Applications covered in the Recombinant Humanized Bisspecific Antibody Market report are Breast Cancer, Stomach Cancer, Other

What are the Type segmentation covered in the Recombinant Humanized Bisspecific Antibody Market report?

Ans: The Types covered in the Recombinant Humanized Bisspecific Antibody Market report are With Fc Area, No Fc Area

1 Recombinant Humanized Bisspecific Antibody Market Overview
1.1 Product Definition
1.2 Recombinant Humanized Bisspecific Antibody by Type
1.2.1 Global Recombinant Humanized Bisspecific Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 With Fc Area
1.2.3 No Fc Area
1.3 Recombinant Humanized Bisspecific Antibody by Application
1.3.1 Global Recombinant Humanized Bisspecific Antibody Market Value by Application (2024 VS 2031)
1.3.2 Breast Cancer
1.3.3 Stomach Cancer
1.3.4 Other
1.4 Global Recombinant Humanized Bisspecific Antibody Market Size Estimates and Forecasts
1.4.1 Global Recombinant Humanized Bisspecific Antibody Revenue 2020-2031
1.4.2 Global Recombinant Humanized Bisspecific Antibody Sales 2020-2031
1.4.3 Global Recombinant Humanized Bisspecific Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Humanized Bisspecific Antibody Market Competition by Manufacturers
2.1 Global Recombinant Humanized Bisspecific Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Humanized Bisspecific Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Humanized Bisspecific Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Humanized Bisspecific Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Humanized Bisspecific Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Humanized Bisspecific Antibody, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Humanized Bisspecific Antibody, Date of Enter into This Industry
2.8 Global Recombinant Humanized Bisspecific Antibody Market Competitive Situation and Trends
2.8.1 Global Recombinant Humanized Bisspecific Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Humanized Bisspecific Antibody Players Market Share by Revenue
2.8.3 Global Recombinant Humanized Bisspecific Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Humanized Bisspecific Antibody Market Scenario by Region
3.1 Global Recombinant Humanized Bisspecific Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Humanized Bisspecific Antibody Sales by Region: 2020-2031
3.2.1 Global Recombinant Humanized Bisspecific Antibody Sales by Region: 2020-2025
3.2.2 Global Recombinant Humanized Bisspecific Antibody Sales by Region: 2026-2031
3.3 Global Recombinant Humanized Bisspecific Antibody Revenue by Region: 2020-2031
3.3.1 Global Recombinant Humanized Bisspecific Antibody Revenue by Region: 2020-2025
3.3.2 Global Recombinant Humanized Bisspecific Antibody Revenue by Region: 2026-2031
3.4 North America Recombinant Humanized Bisspecific Antibody Market Facts & Figures by Country
3.4.1 North America Recombinant Humanized Bisspecific Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Humanized Bisspecific Antibody Sales by Country (2020-2031)
3.4.3 North America Recombinant Humanized Bisspecific Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Humanized Bisspecific Antibody Market Facts & Figures by Country
3.5.1 Europe Recombinant Humanized Bisspecific Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Humanized Bisspecific Antibody Sales by Country (2020-2031)
3.5.3 Europe Recombinant Humanized Bisspecific Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Humanized Bisspecific Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Humanized Bisspecific Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Humanized Bisspecific Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Humanized Bisspecific Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Humanized Bisspecific Antibody Market Facts & Figures by Country
3.7.1 Latin America Recombinant Humanized Bisspecific Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Humanized Bisspecific Antibody Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Humanized Bisspecific Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Humanized Bisspecific Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Humanized Bisspecific Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Humanized Bisspecific Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Humanized Bisspecific Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Humanized Bisspecific Antibody Sales by Type (2020-2031)
4.1.1 Global Recombinant Humanized Bisspecific Antibody Sales by Type (2020-2025)
4.1.2 Global Recombinant Humanized Bisspecific Antibody Sales by Type (2026-2031)
4.1.3 Global Recombinant Humanized Bisspecific Antibody Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Humanized Bisspecific Antibody Revenue by Type (2020-2031)
4.2.1 Global Recombinant Humanized Bisspecific Antibody Revenue by Type (2020-2025)
4.2.2 Global Recombinant Humanized Bisspecific Antibody Revenue by Type (2026-2031)
4.2.3 Global Recombinant Humanized Bisspecific Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Humanized Bisspecific Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Humanized Bisspecific Antibody Sales by Application (2020-2031)
5.1.1 Global Recombinant Humanized Bisspecific Antibody Sales by Application (2020-2025)
5.1.2 Global Recombinant Humanized Bisspecific Antibody Sales by Application (2026-2031)
5.1.3 Global Recombinant Humanized Bisspecific Antibody Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Humanized Bisspecific Antibody Revenue by Application (2020-2031)
5.2.1 Global Recombinant Humanized Bisspecific Antibody Revenue by Application (2020-2025)
5.2.2 Global Recombinant Humanized Bisspecific Antibody Revenue by Application (2026-2031)
5.2.3 Global Recombinant Humanized Bisspecific Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Humanized Bisspecific Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sunshine Guojian Pharmaceutical
6.1.1 Sunshine Guojian Pharmaceutical Company Information
6.1.2 Sunshine Guojian Pharmaceutical Description and Business Overview
6.1.3 Sunshine Guojian Pharmaceutical Recombinant Humanized Bisspecific Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sunshine Guojian Pharmaceutical Recombinant Humanized Bisspecific Antibody Product Portfolio
6.1.5 Sunshine Guojian Pharmaceutical Recent Developments/Updates
6.2 Milestone (Shanghai) Biological Science & Technology
6.2.1 Milestone (Shanghai) Biological Science & Technology Company Information
6.2.2 Milestone (Shanghai) Biological Science & Technology Description and Business Overview
6.2.3 Milestone (Shanghai) Biological Science & Technology Recombinant Humanized Bisspecific Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Milestone (Shanghai) Biological Science & Technology Recombinant Humanized Bisspecific Antibody Product Portfolio
6.2.5 Milestone (Shanghai) Biological Science & Technology Recent Developments/Updates
6.3 Akeso, Inc
6.3.1 Akeso, Inc Company Information
6.3.2 Akeso, Inc Description and Business Overview
6.3.3 Akeso, Inc Recombinant Humanized Bisspecific Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Akeso, Inc Recombinant Humanized Bisspecific Antibody Product Portfolio
6.3.5 Akeso, Inc Recent Developments/Updates
6.4 Alphamab Oncology
6.4.1 Alphamab Oncology Company Information
6.4.2 Alphamab Oncology Description and Business Overview
6.4.3 Alphamab Oncology Recombinant Humanized Bisspecific Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Alphamab Oncology Recombinant Humanized Bisspecific Antibody Product Portfolio
6.4.5 Alphamab Oncology Recent Developments/Updates
6.5 Detai Bio-Tech
6.5.1 Detai Bio-Tech Company Information
6.5.2 Detai Bio-Tech Description and Business Overview
6.5.3 Detai Bio-Tech Recombinant Humanized Bisspecific Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Detai Bio-Tech Recombinant Humanized Bisspecific Antibody Product Portfolio
6.5.5 Detai Bio-Tech Recent Developments/Updates
6.6 Junshi Biosciences
6.6.1 Junshi Biosciences Company Information
6.6.2 Junshi Biosciences Description and Business Overview
6.6.3 Junshi Biosciences Recombinant Humanized Bisspecific Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Junshi Biosciences Recombinant Humanized Bisspecific Antibody Product Portfolio
6.6.5 Junshi Biosciences Recent Developments/Updates
6.7 CSPC Pharmaceutical Group
6.7.1 CSPC Pharmaceutical Group Company Information
6.7.2 CSPC Pharmaceutical Group Description and Business Overview
6.7.3 CSPC Pharmaceutical Group Recombinant Humanized Bisspecific Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CSPC Pharmaceutical Group Recombinant Humanized Bisspecific Antibody Product Portfolio
6.7.5 CSPC Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Humanized Bisspecific Antibody Industry Chain Analysis
7.2 Recombinant Humanized Bisspecific Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Humanized Bisspecific Antibody Production Mode & Process Analysis
7.4 Recombinant Humanized Bisspecific Antibody Sales and Marketing
7.4.1 Recombinant Humanized Bisspecific Antibody Sales Channels
7.4.2 Recombinant Humanized Bisspecific Antibody Distributors
7.5 Recombinant Humanized Bisspecific Antibody Customer Analysis
8 Recombinant Humanized Bisspecific Antibody Market Dynamics
8.1 Recombinant Humanized Bisspecific Antibody Industry Trends
8.2 Recombinant Humanized Bisspecific Antibody Market Drivers
8.3 Recombinant Humanized Bisspecific Antibody Market Challenges
8.4 Recombinant Humanized Bisspecific Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
SUNSHINE GUOJIAN PHARMACEUTICAL
Akeso, Inc.
ALPHAMAB ONCOLOGY
Junshi Biosciences
CSPC Pharmaceutical Group
Milestone (Shanghai) Biological Science & Technology
Detai Bio-Tech
Milestone (Shanghai) Biological Science & Technology
List of Tables
 Table 1. Global Recombinant Humanized Bisspecific Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Humanized Bisspecific Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Humanized Bisspecific Antibody Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Humanized Bisspecific Antibody Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Humanized Bisspecific Antibody Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Humanized Bisspecific Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Humanized Bisspecific Antibody Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Humanized Bisspecific Antibody Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Humanized Bisspecific Antibody, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Humanized Bisspecific Antibody, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Humanized Bisspecific Antibody, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Humanized Bisspecific Antibody, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Humanized Bisspecific Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Humanized Bisspecific Antibody as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Humanized Bisspecific Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Humanized Bisspecific Antibody Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Humanized Bisspecific Antibody Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Humanized Bisspecific Antibody Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Humanized Bisspecific Antibody Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Humanized Bisspecific Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Humanized Bisspecific Antibody Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Humanized Bisspecific Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Humanized Bisspecific Antibody Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Humanized Bisspecific Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Humanized Bisspecific Antibody Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Humanized Bisspecific Antibody Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Humanized Bisspecific Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Humanized Bisspecific Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Humanized Bisspecific Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Humanized Bisspecific Antibody Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Humanized Bisspecific Antibody Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Humanized Bisspecific Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Humanized Bisspecific Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Humanized Bisspecific Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Humanized Bisspecific Antibody Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Humanized Bisspecific Antibody Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Humanized Bisspecific Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Humanized Bisspecific Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Humanized Bisspecific Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Humanized Bisspecific Antibody Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Humanized Bisspecific Antibody Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Humanized Bisspecific Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Humanized Bisspecific Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Humanized Bisspecific Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Humanized Bisspecific Antibody Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Humanized Bisspecific Antibody Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Humanized Bisspecific Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Humanized Bisspecific Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Humanized Bisspecific Antibody Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Humanized Bisspecific Antibody Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Humanized Bisspecific Antibody Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Humanized Bisspecific Antibody Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Humanized Bisspecific Antibody Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Humanized Bisspecific Antibody Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Humanized Bisspecific Antibody Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Humanized Bisspecific Antibody Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Humanized Bisspecific Antibody Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Humanized Bisspecific Antibody Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Humanized Bisspecific Antibody Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Humanized Bisspecific Antibody Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Humanized Bisspecific Antibody Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Humanized Bisspecific Antibody Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Humanized Bisspecific Antibody Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Humanized Bisspecific Antibody Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Humanized Bisspecific Antibody Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Humanized Bisspecific Antibody Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Humanized Bisspecific Antibody Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Humanized Bisspecific Antibody Price (US$/Unit) by Application (2026-2031)
 Table 70. Sunshine Guojian Pharmaceutical Company Information
 Table 71. Sunshine Guojian Pharmaceutical Description and Business Overview
 Table 72. Sunshine Guojian Pharmaceutical Recombinant Humanized Bisspecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sunshine Guojian Pharmaceutical Recombinant Humanized Bisspecific Antibody Product
 Table 74. Sunshine Guojian Pharmaceutical Recent Developments/Updates
 Table 75. Milestone (Shanghai) Biological Science & Technology Company Information
 Table 76. Milestone (Shanghai) Biological Science & Technology Description and Business Overview
 Table 77. Milestone (Shanghai) Biological Science & Technology Recombinant Humanized Bisspecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Milestone (Shanghai) Biological Science & Technology Recombinant Humanized Bisspecific Antibody Product
 Table 79. Milestone (Shanghai) Biological Science & Technology Recent Developments/Updates
 Table 80. Akeso, Inc Company Information
 Table 81. Akeso, Inc Description and Business Overview
 Table 82. Akeso, Inc Recombinant Humanized Bisspecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Akeso, Inc Recombinant Humanized Bisspecific Antibody Product
 Table 84. Akeso, Inc Recent Developments/Updates
 Table 85. Alphamab Oncology Company Information
 Table 86. Alphamab Oncology Description and Business Overview
 Table 87. Alphamab Oncology Recombinant Humanized Bisspecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Alphamab Oncology Recombinant Humanized Bisspecific Antibody Product
 Table 89. Alphamab Oncology Recent Developments/Updates
 Table 90. Detai Bio-Tech Company Information
 Table 91. Detai Bio-Tech Description and Business Overview
 Table 92. Detai Bio-Tech Recombinant Humanized Bisspecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Detai Bio-Tech Recombinant Humanized Bisspecific Antibody Product
 Table 94. Detai Bio-Tech Recent Developments/Updates
 Table 95. Junshi Biosciences Company Information
 Table 96. Junshi Biosciences Description and Business Overview
 Table 97. Junshi Biosciences Recombinant Humanized Bisspecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Junshi Biosciences Recombinant Humanized Bisspecific Antibody Product
 Table 99. Junshi Biosciences Recent Developments/Updates
 Table 100. CSPC Pharmaceutical Group Company Information
 Table 101. CSPC Pharmaceutical Group Description and Business Overview
 Table 102. CSPC Pharmaceutical Group Recombinant Humanized Bisspecific Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. CSPC Pharmaceutical Group Recombinant Humanized Bisspecific Antibody Product
 Table 104. CSPC Pharmaceutical Group Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Recombinant Humanized Bisspecific Antibody Distributors List
 Table 108. Recombinant Humanized Bisspecific Antibody Customers List
 Table 109. Recombinant Humanized Bisspecific Antibody Market Trends
 Table 110. Recombinant Humanized Bisspecific Antibody Market Drivers
 Table 111. Recombinant Humanized Bisspecific Antibody Market Challenges
 Table 112. Recombinant Humanized Bisspecific Antibody Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Humanized Bisspecific Antibody
 Figure 2. Global Recombinant Humanized Bisspecific Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Humanized Bisspecific Antibody Market Share by Type: 2024 & 2031
 Figure 4. With Fc Area Product Picture
 Figure 5. No Fc Area Product Picture
 Figure 6. Global Recombinant Humanized Bisspecific Antibody Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Recombinant Humanized Bisspecific Antibody Market Share by Application: 2024 & 2031
 Figure 8. Breast Cancer
 Figure 9. Stomach Cancer
 Figure 10. Other
 Figure 11. Global Recombinant Humanized Bisspecific Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Recombinant Humanized Bisspecific Antibody Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Recombinant Humanized Bisspecific Antibody Sales (2020-2031) & (K Units)
 Figure 14. Global Recombinant Humanized Bisspecific Antibody Average Price (US$/Unit) & (2020-2031)
 Figure 15. Recombinant Humanized Bisspecific Antibody Report Years Considered
 Figure 16. Recombinant Humanized Bisspecific Antibody Sales Share by Manufacturers in 2024
 Figure 17. Global Recombinant Humanized Bisspecific Antibody Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Recombinant Humanized Bisspecific Antibody Players: Market Share by Revenue in Recombinant Humanized Bisspecific Antibody in 2024
 Figure 19. Recombinant Humanized Bisspecific Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Recombinant Humanized Bisspecific Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Recombinant Humanized Bisspecific Antibody Sales Market Share by Country (2020-2031)
 Figure 22. North America Recombinant Humanized Bisspecific Antibody Revenue Market Share by Country (2020-2031)
 Figure 23. United States Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Recombinant Humanized Bisspecific Antibody Sales Market Share by Country (2020-2031)
 Figure 26. Europe Recombinant Humanized Bisspecific Antibody Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Recombinant Humanized Bisspecific Antibody Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Recombinant Humanized Bisspecific Antibody Revenue Market Share by Region (2020-2031)
 Figure 34. China Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Recombinant Humanized Bisspecific Antibody Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Recombinant Humanized Bisspecific Antibody Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Recombinant Humanized Bisspecific Antibody Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Recombinant Humanized Bisspecific Antibody Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Recombinant Humanized Bisspecific Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Recombinant Humanized Bisspecific Antibody by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Recombinant Humanized Bisspecific Antibody by Type (2020-2031)
 Figure 54. Global Recombinant Humanized Bisspecific Antibody Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Recombinant Humanized Bisspecific Antibody by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Recombinant Humanized Bisspecific Antibody by Application (2020-2031)
 Figure 57. Global Recombinant Humanized Bisspecific Antibody Price (US$/Unit) by Application (2020-2031)
 Figure 58. Recombinant Humanized Bisspecific Antibody Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Humanized Bispecific Antibody Market Research Report 2024
Global Humanized Bispecific Antibodies Market Research Report 2024
Global CTLA 4 Antibody Market Research Report 2024
Global Bi Specific MAbS Market Research Report 2024
Global Bispecific Antibody Development Platform Market Research Report 2024
Global Bispecific Antibodies for Cancer Market Insights Forecast to 2030
Global Humanized Antibody Market Research Report 2024
Global Fully Humanized Monoclonal Antibody Market Research Report 2024
Global Bispecific Antibody Molecular Drug Market Research Report 2025
Global Humanized Monoclonal Antibody Market Research Report 2024
Global Bispecific Antibodies Drug Market Research Report 2025
Global T Cell NK Cell Engaging Bispecific Antibodies Market Research Report 2025
Bispecific and Trispecific Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bispecific Antibody Technology Platform Market Research Report 2025
Global Ipilimumab Market Research Report 2024
Bispecific Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CD Targeted Bispecific Antibody Market Research Report 2024
Global PD 1 and PD L1 Antibody Market Insights Forecast to 2030
Global PD 1 and PD L1 Monoclonal Antibody Market Research Report 2025
Fully Humanized Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions